株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポジトロン放出断層撮影 (PET) 装置の世界市場:医療機器のパイプライン評価

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 358892
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
ポジトロン放出断層撮影 (PET) 装置の世界市場:医療機器のパイプライン評価 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019
出版日: 2019年05月01日 ページ情報: 英文 82 Pages
概要

当レポートでは、世界のポジトロン放出断層撮影 (以下PET) システムの市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 陽電子放出断層撮影 (PET) システムの概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • PET装置の企業:治験段階別のパイプライン製品
  • PET装置:治験段階別のパイプライン製品

第5章 PET装置市場:企業・製品の概要

  • Brain Biosciences Inc
    • パイプライン製品および進行中の治験の概要
  • GE Healthcare Limited
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • The University of British Columbia
  • Zecotek Photonics Inc.

第6章 PET装置市場:昨今の動向

第7章 付録

図表一覧

図表

1.1 List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: CerePET - Product Status
  • Table 9: CerePET - Product Description
  • Table 10: FREEMotion - Product Status
  • Table 11: FREEMotion - Product Description
  • Table 12: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Q.Clear - Product Status
  • Table 14: Q.Clear - Product Description
  • Table 15: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: CareMiBrain - Product Status
  • Table 17: CareMiBrain - Product Description
  • Table 18: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Positron Emission Tomography System - Product Status
  • Table 20: Positron Emission Tomography System - Product Description
  • Table 21: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: HARLI - Product Status
  • Table 23: HARLI - Product Description
  • Table 24: Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: NVL1 Diagnostic Tracer - Product Status
  • Table 26: NVL1 Diagnostic Tracer - Product Description
  • Table 27: Nuclear, Plasma, and Radiological Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Head And Neck PET System - Product Status
  • Table 29: Head And Neck PET System - Product Description
  • Table 30: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Additional PET Scan - Product Status
  • Table 32: Additional PET Scan - Product Description
  • Table 33: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Helmet - PET System - Product Status
  • Table 35: Helmet - PET System - Product Description
  • Table 36: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Breast-Dedicated PET System - Product Status
  • Table 38: Breast-Dedicated PET System - Product Description
  • Table 39: Dual Panel PET Scanner - Product Status
  • Table 40: Dual Panel PET Scanner - Product Description
  • Table 41: Dual-isotope Positron Emitting Tomography System - Product Status
  • Table 42: Dual-isotope Positron Emitting Tomography System - Product Description
  • Table 43: MR Compatible PET System - Product Status
  • Table 44: MR Compatible PET System - Product Description
  • Table 45: Next Generation TOF-PET System - Product Status
  • Table 46: Next Generation TOF-PET System - Product Description
  • Table 47: PET Sensitivity Enhancing Device - Product Status
  • Table 48: PET Sensitivity Enhancing Device - Product Description
  • Table 49: PET System - Product Status
  • Table 50: PET System - Product Description
  • Table 51: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Arterial PET Scanner - Product Status
  • Table 53: Arterial PET Scanner - Product Description
  • Table 54: Breast PET-MRI - Product Status
  • Table 55: Breast PET-MRI - Product Description
  • Table 56: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: PET Imaging Tool - Product Status
  • Table 58: PET Imaging Tool - Product Description
  • Table 59: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: DS-PS3 Positron Emission Tomography Detector - Product Status
  • Table 61: DS-PS3 Positron Emission Tomography Detector - Product Description
  • Table 62: High Resolution PET Detector - Product Status
  • Table 63: High Resolution PET Detector - Product Description
  • Table 64: PET-Mammogram-Biopsy System - Product Status
  • Table 65: PET-Mammogram-Biopsy System - Product Description
  • Table 66: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Positron Emission Tomography (PET) Imager - Product Status
  • Table 68: Positron Emission Tomography (PET) Imager - Product Description
  • Table 69: Glossary

1.2 List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
目次
Product Code: GDME0767EPD

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

  • 2.1 Positron Emission Tomography (PET) Systems Overview

3 Products under Development

  • 3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • 3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • 3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • 3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date

4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies

  • 4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • 4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development

5 Positron Emission Tomography (PET) Systems Companies and Product Overview

  • 5.1 Brain Biosciences Inc Company Overview
  • 5.2 GE Healthcare LLC Company Overview
  • 5.3 General De Equipment for Medical Imaging SA Company Overview
  • 5.4 Jagiellonian University Company Overview
  • 5.5 Lightpoint Medical Ltd Company Overview
  • 5.6 Neurovation Labs Inc Company Overview
  • 5.7 Nuclear, Plasma, and Radiological Engineering Company Overview
  • 5.8 Philips Healthcare Company Overview
  • 5.9 Ray Vision Intl Corp. Company Overview
  • 5.10 Stanford University Company Overview
  • 5.11 SynchroPET Company Overview
  • 5.12 University of British Columbia Company Overview
  • 5.13 University of Washington Company Overview
  • 5.14 West Virginia University Company Overview

6 Positron Emission Tomography (PET) Systems- Recent Developments

  • 6.1 Mar 25, 2019: Inflazome receives funding from The Michael J. Fox Foundation for Parkinson's Research
  • 6.2 Mar 18, 2019: European Association of Urology issues updated guidelines for prostate cancer imaging

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top